Threshold Pharma (THLD) Tops Q3 EPS by 5c

November 2, 2015 7:02 AM EST

Threshold Pharma (NASDAQ: THLD) reported Q3 EPS of ($0.09), $0.05 better than the analyst estimate of ($0.14). Revenue for the quarter came in at $3.7 million versus the consensus estimate of $3.69 million.

For earnings history and earnings-related data on Threshold Pharma (THLD) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings